Publications
|
Wang C, Tran-Thanh D, Moreno JC, Cawthorn TR, Jacks
LM, Wang DY, McCready DR, Done SJ. Expression of Abl interactor 1 and its
prognostic significance in breast cancer: a tissue-array-based
investigation. Breast Cancer Res Treat. 2010 Nov 3. [Epub
ahead of print]
|
|
View Abstract
|
|
Tran-Thanh
D, Arneson NC,
Pintilie M, Deliallisi A, Warren
KS, Bane A, Done SJ. Amplification of the prolactin receptor gene in
mammary lobular neoplasia. Breast Cancer Res Treat. 2010 Jul
24. PMID: 20658264
|
|
View Abstract
|
|
Rashid-Kolvear
F, Taboski MA, Nguyen J, Wang DY, Harrington LA, Done SJ. Troglitazone suppresses telomerase activity
independently of PPARgamma in estrogen-receptor negative breast cancer
cells. BMC Cancer. 2010 Jul 22;10:390.PMID: 20650001
|
|
View Abstract
|
|
Costantini
DL, McLarty K, Lee H, Done SJ, Vallis KA, Reilly RM. Antitumor effects and normal-tissue toxicity of
111In-nuclear localization sequence-trastuzumab in athymic mice bearing
HER-positive human breast cancer xenografts. J Nucl Med. 2010
Jul;51(7):1084-91. Epub 2010 Jun 16.PMID: 20554744
|
|
View Abstract
|
|
Williamson
D, Dinniwell R, Fung S, Pintilie M, Done SJ, Fyles AW. Local control with conventional and
hypofractionated adjuvant radiotherapy after breast-conserving surgery
for ductal carcinoma in-situ. Radiother Oncol. 2010
Jun;95(3):317-20. Epub 2010 Apr 17.PMID: 20400190
|
|
View Abstract
|
|
Tran-Thanh
D, Buttars S, Wen Y, Wilson C, Done SJ. Cyclooxygenase-2 inhibition for the prophylaxis
and treatment of preinvasive breast cancer in a her-2/neu mouse model.
Cancer Prev Res (Phila). 2010 Feb;3(2):202-11. Epub 2010 Jan 26.PMID:
20103725
|
|
View Abstract
|
|
Tran-Thanh
D, Done SJ. The role of stromal factors in breast
tumorigenicity. Am J Pathol. 2010 Mar;176(3):1072-4. Epub 2010
Jan 21. No abstract available. PMID: 20093480
|
|
View Abstract
|
|
McLarty
K, Fasih A, Scollard DA, Done SJ, Vines DC, Green DE, Costantini DL,
Reilly RM. 18F-FDG small-animal PET/CT differentiates
trastuzumab-responsive from unresponsive human breast cancer xenografts
in athymic mice. J Nucl Med. 2009 Nov;50(11):1848-56. Epub
2009 Oct 16.PMID: 19837760
|
|
View Abstract
|
|
Wang
C, Iakovlev VV, Wong V, Leung S, Warren K, Iakovleva G, Arneson NC,
Pintilie M, Miller N, Youngson B, McCready DR, Done SJ. Genomic alterations in primary breast cancers compared
with their sentinel and more distal lymph node metastases: an aCGH study.
Genes Chromosomes Cancer. 2009 Dec;48(12):1091-101.PMID: 19760610
|
|
View Abstract
|
|
Douplik
A, Leong WL, Easson AM, Done S, Netchev G, Wilson BC. Feasibility study of autofluorescence mammary
ductoscopy. J Biomed Opt. 2009 Jul-Aug;14(4):044036.PMID:
19725747
|
|
View Abstract
|
|
McLarty
K, Cornelissen B, Cai Z, Scollard DA, Costantini DL, Done SJ, Reilly RM. Micro-SPECT/CT with 111In-DTPA-pertuzumab
sensitively detects trastuzumab-mediated HER2 downregulation and tumor
response in athymic mice bearing MDA-MB-361 human breast cancer
xenografts. J Nucl Med. 2009 Aug;50(8):1340-8. Epub 2009 Jul
17.PMID: 19617342
|
|
View Abstract
|
|
Wong
V, Wang DY, Warren K, Kulkarni S, Boerner S, Done SJ, Leong WL. The effects of timing of fine needle aspiration
biopsies on gene expression profiles in breast cancers. BMC
Cancer. 2008 Sep 30;8:277.PMID: 18826606. Free PMC Article
|
|
View Abstract
|
|
McLarty
K, Cornelissen B, Scollard DA, Done SJ, Chun K, Reilly RM. Associations between the uptake of
111In-DTPA-trastuzumab, HER2 density and response to trastuzumab
(Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):81-93. Epub 2008 Aug 19.PMID:
18712381
|
|
View Abstract
|
|
Iakovlev
VV, Arneson NC, Wong V, Wang C, Leung S, Iakovleva G, Warren K, Pintilie
M, Done SJ. Genomic differences between pure ductal
carcinoma in situ of the breast and that associated with invasive
disease: a calibrated aCGH study. Clin Cancer Res. 2008 Jul
15;14(14):4446-54.PMID: 18628458
|
|
View Abstract
|
|
Wang
C, Navab R, Iakovlev V, Leng Y, Zhang J, Tsao MS, Siminovitch K, McCready
DR, Done SJ. Abelson interactor protein-1 positively
regulates breast cancer cell proliferation, migration, and invasion.
Mol Cancer Res. 2007 Oct;5(10):1031-9.PMID: 17951403
|
|
View Abstract
|
|
McKenna
AM, Pintilie M, Youngson B, Done SJ. Quantification of the morphologic features of
fibroepithelial tumors of the breast. Arch Pathol Lab Med.
2007 Oct;131(10):1568-73.PMID: 17922594
|
|
View Abstract
|
|
Ghazani,
A.A., Arneson, N.C., Warren, K., Qiao, W., Pintilie, M., Bayani, J.,
Squire, J.A., Done S.J. Genomic Alterations in Sporadic Synchronous
Breast Cancer Using Array and Chromosomal Comparative Genomic
Hybridization. 2006. Click here to download supplemental data.
|
|
View Abstract
|
|
Ghazani
A.A., Arneson N.C., Warren K., Done S.J. Limited
tissue fixation times and whole genomic amplification do not impact array
CGH profiles. J Clin Pathol, 59: 311-15, 2006.
|
|
View Abstract
|
|
Cully
M., Shiu J., Piekorz R.P., Muller W.J., Done S.J., Mak T.W. Transforming
acidic coiled coil 1 promotes transformation and mammary tumorigenesis.
Cancer Res, 65: 10363-70, 2005.
|
|
View Abstract
|
|
To
M.D., Faseruk S.A.,
Gokgoz N., Pinnaduwage D., Done S.J., Andrulis I.L. LAF-4 is aberrantly
expressed in human breast cancer. Int J Cancer, 115: 568-74, 2005.
|
|
View Abstract
|
|
Hughes
S., Arneson N., Done S., Squire J. The use of whole genome amplification
in the study of human disease. Prog Biophys Mol Biol, 88: 173-89, 2005.
|
|
View Abstract
|
|
McCready,
D.R., Yong, W.S., Ng, A.K., Miller, N., Done, S., and Youngson, B.
Influence of the new AJCC breast cancer staging system on sentinel lymph
node positivity and false-negative rates. J Natl Cancer Inst, 96:
873-875, 2004.
|
|
View Abstract
|
|
Cheung,
A.M., Elia, A., Tsao, M.S., Done, S., Wagner, K.U., Hennighausen, L.,
Hakem, R., and Mak, T.W. Brca2 deficiency does not impair mammary
epithelium development but promotes mammary adenocarcinoma formation in
p53(+/-) mutant mice. Cancer Res, 64: 1959-1965, 2004.
|
|
View Abstract
|
|
Done,
S.J., Eskandarian, S., Bull, S., Redston, M., and Andrulis, I.L. p53
missense mutations in microdissected high-grade ductal carcinoma in situ
of the breast. J Natl Cancer Inst, 93: 700-704, 2001. (Also see Editorial
Comment below.)
|
|
View Abstract
|
|
Simpson,
J.F., Page, D.L., and Edgerton,
M.E. p53 in Mammary ductal
carcinoma in situ, mutations in high-grade lesions only? J Natl Cancer
Inst, 93: 666-667, 2001.
|
|
View Abstract
|
|
Done,
S.J., Arneson, C.R., Ozcelik, H., Redston, M., and Andrulis, I.L. p53
protein accumulation in non-invasive lesions surrounding p53 mutation
positive invasive breast cancers. Breast Cancer Res Treat, 65: 111-118,
2001.
|
|
View Abstract
|
|
Khoo,
U.S., Ozcelik, H., Cheung, A.N., Chow, L.W., Ngan, H.Y., Done, S.J.,
Liang, A.C., Chan, V.W., Au, G.K., Ng, W.F., Poon, C.S., Leung, Y.F.,
Loong, F., Ip, P., Chan, G.S., Andrulis, I.L., Lu, J., and Ho, F.C.
Somatic mutations in the BRCA1 gene in Chinese sporadic breast and
ovarian cancer. Oncogene, 18: 4643-4646, 1999.
|
|
View Abstract
|
|
Phillips,
K.A., Nichol, K., Ozcelik, H., Knight, J., Done, S.J., Goodwin, P. J.,
and Andrulis, I.L. Frequency of p53 mutations in breast carcinomas from
Ashkenazi Jewish carriers of BRCA1 mutations. J Natl Cancer Inst, 91:
469-473, 1999.
|
|
View Abstract
|
|
To,
M.D., Done, S.J., Redston, M., and Andrulis, I.L. Analysis of mRNA from
microdissected frozen tissue sections without RNA isolation. Am J Pathol,
153: 47-51, 1998.
|
|
View Abstract
|
|
Done,
S.J., Arneson, N.C., Ozcelik, H., Redston, M., and
Andrulis, I.L. p53 mutations in mammary ductal carcinoma in situ but not
in epithelial hyperplasias. Cancer Res, 58: 785-789, 1998.
|
|
View Abstract
|
|
|
|
